Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin renal handling in adults with renal impairment
ACTRN12614001180606Phase 4Terminated
- Sponsor
- Dr Dan Wright
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in nephropathy (3 cohorts), sponsored by Dr Dan Wright. Primary endpoint: Metformin renal clearance. Started Nov 2014; status: terminated.
02
Drugs
metformin
03
Conditions
nephropathy
Beyond the preview
Go deeper on ACTRN12614001180606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001180606.